Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results